Search for Clinical Trial Results

Alveolar Soft Part Sarcoma - 24 Studies Found
Status | Study |
Terminated |
Study Name: Pazopanib for Metastatic Alveolar Soft Part Sarcoma Condition: Metastatic Alveolar Soft Part Sarcoma Date: 2014-04-09 Interventions: Drug: Pazopanib Pazopanib 800mg qd daily for 4 weeks = 1 cycle |
Recruiting |
Study Name: A Phase 2 Study of Anti-PD-L1 Antibody Atezolizumab in Alveolar Soft Part Sarcoma Condition: Alveolar Soft Part Sarcoma Date: 2017-05-03 Interventions: Drug: Atezolizumab Atezolizumab is a human monoclonal antibody directed against programmed death-ligand |
Active, not recruiting |
Study Name: A Trial of Cediranib in the Treatment of Patients With Alveolar Soft Part Sarcoma (CASPS) Condition: Alveolar Soft-part Sarcoma Date: 2011-04-11 Interventions:
|
Recruiting |
Study Name: Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas Condition:
Date: 2015-12-14 Interventions:
|
Completed |
Study Name: Collection of Alveolar Soft Part Sarcoma and Blood Specimens for Research Condition:
Date: 2006-06-19 |
Not yet recruiting |
Study Name: A Phase III Trial of Anlotinib in Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma Condition:
|
Recruiting |
Study Name: Sunitinib or Cediranib for Alveolar Soft Part Sarcoma Condition: Sarcoma, Alveolar Soft Part Date: 2011-07-09 Interventions:
|
Recruiting |
Study Name: Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma Condition: Sarcoma, Alveolar Soft Part Date: 2009-07-18 Interventions: Drug: AZD2171 Cediranib (AZD2171), a VEGF/KIT tyrosine kinase inhibitor, has demonstrated antitumor acti |
Completed |
Study Name: A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas Condition:
|
Completed |
Study Name: Phase 2 Study in Patients With MiT Tumors Condition:
|